← Back
$RYTM All transactions

RHYTHM PHARMACEUTICALS, INC.

A

$ Value

$0

Shares

4,712

Price

$0

Filed

Jun 26

Insider

Name

Mathers Edward T

Title

CIK

0001328625

Roles

Director

Transaction Details

Transaction Date

2025-06-24

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

4,712

Footnotes

The options fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date. | Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. | The restricted stock units fully vest upon the earlier of (i) June 24, 2026 or (ii) the day immediately prior to the date of the Issuer's next annual meeting of the stockholders to be held in 2026, subject to the Reporting Person's continued service on such vesting date. The restricted stock units have no expiration date.

Filing Info

Accession No.

0000950170-25-090454

Form Type

4

Issuer CIK

0001649904

Mathers Edward T's History

Date Ticker Type Value
2025-12-31 OKUR A $0
2025-10-02 NEUE X $2K
2025-10-02 NEUE $2K
2025-10-02 NEUE M $2K
2025-10-02 NEUE F $2K
2025-10-02 NEUE D
2025-10-02 NEUE X $17K
2025-10-02 NEUE $17K
2025-10-02 NEUE X $6K
2025-10-02 NEUE $6K

Other Insiders at RYTM (90d)

Insider Bought Sold Last
German Christopher Paul
Corporate Controller & CAO
2026-02-01
Popovits Kimberly J 2026-04-01
Meeker David P
President and CEO
2026-02-01
Smith Hunter C
Chief Financial Officer
$703K 2026-02-05
Mazabraud Yann
EVP, Head of International
2026-04-01
Lee Jennifer Kayden
EVP, Head of North America
2026-02-01
Cramer Pamela J.
Chief Human Resources Officer
2026-02-01
Shulman Joseph
Chief Technical Officer
2026-02-01
Garfield Alastair
Chief Scientific Officer
2026-02-01